The rhinotopic protocol for chronic refractory rhinosinusitis: how we do it.
Shikani
A H
AH
Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA. ashikani@aol.com
Chahine
K A
KA
Alqudah
M A
MA
D000293:Adolescent; D000328:Adult; D000368:Aged; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D003646:Debridement / Q000379:methods*; D004724:Endoscopy / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D000068656:Mometasone Furoate; D055556:Nasal Lavage / Q000379:methods*; D011244:Pregnadienediols / Q000008:administration & dosage; D012220:Rhinitis / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D012852:Sinusitis / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D016896:Treatment Outcome; D055815:Young Adult
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D011244:Pregnadienediols; D000068656:Mometasone Furoate